Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Beta-521

Home DrugsBeta-521

Beta-521

Unknown Manufacturer

Generate AI report

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Patents

One entry per invention. Patent families filed in the US, EP, WO and CN offices.

Recombinant laminin-521
Applicant: TRYGGVASON KARLPriority: 2011
US
4 publications
Cell culture substrate comprising a laminin and a cadherin
Applicant: BIOLAMINA ABPriority: 2012
US
2 publications
Novel treatment of cornea using laminin
Applicant: KYOTO PREFECTURAL PUBLIC UNIV CORPPriority: 2014
CN
2 publications
Inclusion daidzein/cyclodextrin composition, and its preparing method
Applicant: NANJING UNIVERSITY OF TECHNOLOGYPriority: 2005
CN